Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS National Generic Pharmaceuticals Wave 13

Atamis Ltd

This public procurement record has 2 releases in its history.

TenderCancellation

19 Jan 2022 at 14:51

Tender Notice
Award

19 Jan 2022 at 14:45

Award Notice
Summary of the contracting process

The procurement process for the "NHS National Generic Pharmaceuticals Wave 13" was managed by ATAMIS LTD, a key contracting authority in the healthcare sector. This procurement falls under the pharmaceutical products category and involves a framework agreement that has a total maximum duration of 28 months, with the possibility of extension up to 48 months. Key dates include the contract start date of 1st February 2022 and an end date of 31st May 2024. The tender was conducted using an open procurement method, with an estimated value of £469,741,550 and delivery expected across multiple regions of the United Kingdom.

This tender presents significant business growth opportunities for companies in the pharmaceutical sector, especially those that can deliver generic medicines. Small and medium-sized enterprises (SMEs) are particularly well-suited to participate, as the procurement specifies suitability for SMEs. Competitors such as Pfizer Ltd and GlaxoSmithKline UK Limited, along with numerous other suppliers, highlight the competitive landscape. Businesses should be prepared to meet the quality and regulatory standards required by the NHS to successfully bid for this contract.

How relevant is this notice?

Notice Information

Notice Title

NHS National Generic Pharmaceuticals Wave 13

Notice Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Transition (Everolimus) CESW: 1 March 2022 - 30 September 2023 (19 months) LSNE: 1 March 2022 - 31 January 2023 (11 months) NWLN: 1 March 2022 - 31 January 2023 (11 months) Oral Products plus non-parenterals All Regions: 1 March 2022 - 31 May 2024 (27 months) Hospital Only Products CESW: 1 February 2022 - 30 September 2023 (20 months) LSNE: 1 February 2022 - 31 May 2024 (28 months) NWLN: 1 February 2022 - 31 January 2023 (12 months)

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-b5fd17-3856df43-01d6-4042-a1e6-a1524397d100
Publication Source
Contracts Finder
Latest Notice
https://www.contractsfinder.service.gov.uk/Notice/2b45447f-b07a-4024-8b3a-2a2f2fd86749
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure (below threshold)
Tender Suitability
SME
Awardee Scale
SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£469,741,550 £100M-£1B
Lots Value
Not specified
Awards Value
£469,741,550 £100M-£1B
Contracts Value
Not specified

Notice Dates

Publication Date
19 Jan 20224 years ago
Submission Deadline
26 Jul 2021Expired
Future Notice Date
Not specified
Award Date
30 Nov 20214 years ago
Contract Period
1 Feb 2022 - 31 May 2024 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Cancelled
Lots Status
Not Specified
Awards Status
Active
Contracts Status
Not Specified

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Atamis Ltd
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
TLC North East (England), TLD North West (England), TLE Yorkshire and The Humber, TLF East Midlands (England), TLG West Midlands (England), TLI London, TLJ South East (England), TLK South West (England)
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
99
Supplier Names

Pfizer Ltd

Merck Sharpe & Dohme (UK) Limited

Allergan

Medreich PLC

Ennogen Healthcare Ltd

GlaxoSmithKline UK Limited

Syri Limited (T/A Thame Laboratories)

hameln pharma ltd

medac Pharma LLP

Martindale Pharma

Rosemont Pharmaceuticals Ltd

Mercury Pharmaceuticals Ltd

Selective Supplies Ltd

Nexcape Pharmaceuticals Ltd.

Consilient Health Ltd

Sandoz Ltd

Fresenius Kabi Limited

Glenmark Pharmaceuticals Europe Ltd

Laboratorio Reig Jofre SA

Kent Pharma Ltd

Bowmed Ibisqus Limited

Panpharma UK Limited

Kensington Pharma Ltd

Healthcare Pharma Ltd

THORNTON & ROSS LIMITED

Mylan

Macleods Pharma UK Limited

Wockhardt UK Limited

Thea Pharmaceuticals Limited

Dr Falk Pharma UK Ltd

Desitin Pharma Ltd

Stragen UK Ltd

B. Braun Medical Limited

Torrent Pharma UK Ltd

Fontus Health Ltd

Aspire Pharma Ltd

Teva UK Limited

Amarox Limited

AOP Orphan Ltd

PIERRE FABRE LIMITED

Macure Pharma ApS

Ranbaxy (UK) Ltd

Arcadia Pharma Ltd T/A Arcadia Medical

Derma UK

Zista Pharma Ltd

Dr.Reddy's Laboratories (UK) Limited

Aspen Pharmacare UK Limited

Manx Healthcare Ltd

Colonis Pharma Ltd

Roche Products Ltd

Waverley Pharma Europe Limited

Profile Pharma Ltd

Reckitt Benckiser

Zentiva Pharma UK Ltd

Baxter Healthcare Ltd

Organon Pharmaceuticals UK Ltd

Day Lewis Medical Ltd

LogixX Pharma Ltd

Lundbeck Limited

Napp Pharmaceuticals Ltd

Bayer Plc

Recordati Rare Diseases UK Ltd

Morningside Pharmaeuticals

Dexcel Pharma Ltd

CST Pharma Limited

Cipla (EU) Limited

Flexipharm Austrading Limited

Relonchem Ltd

LEO Pharma

Aguettant Ltd

Torbay Pharmaceuticals

RPH Pharmaceuticals AB

Drugsrus Ltd

Ferring Pharmaceuticals Ltd

Milpharm Ltd/aurobinbdo

PARI

Crescent Pharma Limited

Roma Pharmaceuticals Limited

Kyowa Kirin Ltd

Brown & Burk UK Ltd

Seacross Pharmaceuticals Ltd

Lupin Healthcare UK Ltd

Alliance Pharmaceuticals Limited

Bristol Laboratories Limited

Aristo Pharma Limited

Synchrony

Alissa Healthcare Research Limited

Altan Pharma Ltd

Lucane Pharma

Norgine Pharmaceuticals Limited

Neon Healthcare Ltd

AVENTIS PHARMA LIMITED t-a Sanofi

MIP Pharma GmbH

Accord-UK Ltd

ACIUM LTD

Ascend Laboratories UK Ltd

Rivopharm UK Ltd

Strides Pharma Uk LTD

V Pharma

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...